Stockscreener 앱 받기
11.77
1.67%
-0.20
시간 외 거래:
11.72
-0.05
-0.42%
전일 마감가:
$11.97
열려 있는:
$11.97
하루 거래량:
1.16M
Relative Volume:
0.77
시가총액:
$626.48M
수익:
$312.78M
순이익/손실:
$-143.56M
주가수익비율:
-4.3755
EPS:
-2.69
순현금흐름:
$1.22M
1주 성능:
-6.59%
1개월 성능:
-41.53%
6개월 성능:
-48.40%
1년 성능:
-56.46%
1일 변동 폭
$11.72
$12.19
1주일 범위
$11.26
$13.28
52주 변동 폭
$10.96
$34.84
Caredx Inc Stock (CDNA) Company Profile
명칭
Caredx Inc
전화
415-287-2300
주소
8000 MARINA BLVD, BRISBANE, CA
CDNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
11.77 | 637.13M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
462.39 | 173.97B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.76 | 143.61B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.11 | 52.65B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.13 | 32.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
180.09 | 30.58B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Underweight |
| 2024-08-19 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-05-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-11-09 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-03-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-03-03 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2021-07-20 | 재개 | BTIG Research | Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-26 | 개시 | BTIG Research | Buy |
| 2020-06-19 | 재확인 | H.C. Wainwright | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-05-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 개시 | Jefferies | Buy |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Neutral |
| 2017-11-27 | 개시 | H.C. Wainwright | Buy |
| 2016-06-14 | 재확인 | Mizuho | Buy |
| 2015-09-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 개시 | Craig Hallum | Buy |
| 2015-03-18 | 재확인 | Mizuho | Buy |
모두보기
Caredx Inc 주식(CDNA)의 최신 뉴스
CareDx's Q2 2025 Earnings: Unpacking Contradictions in EPIC Launch, Legal Settlements, and Volume Growth - AInvest
CareDx Reports Strong Growth in Testing Services - MSN
CareDx, Inc (NASDAQ:CDNA) Q2 2025 Earnings Call Transcript - Insider Monkey
CareDx (CDNA): Analyst Lowers Price Target, Maintains Rating | C - GuruFocus
CareDx Q2 2025 slides: 14% revenue growth despite analyst miss, EBITDA surges - Investing.com
How CareDx Inc stock performs during market volatility300% Return Stock Forecast - classian.co.kr
CareDx Publishes KOAR Study In American Journal of Transplantation, Showcasing AlloSure Dd-cfDNA For Enhanced Kidney Rejection Detection And Biopsy Guidance - 富途牛牛
CareDx Inc. Reports Strong Growth Amid Challenges - TipRanks
CareDx secretary Novack sells $34,380 in shares - Investing.com
CareDx secretary Novack sells $34,380 in shares By Investing.com - Investing.com India
CareDx Appoints New CFO Amid Financial Growth - MSN
CareDx Faces Financial Challenges Amid Mixed Signals and Policy Uncertainties - TipRanks
CareDx 2025 Q2 Earnings EPS Beats Expectations, Net Loss Widens - AInvest
CareDx narrows 2025 revenue guidance to $367M-$373M as kidney surveillance protocols expand - MSN
CareDx Names Nathan Smith as Chief Financial Officer - MarketScreener
CareDx (CDNA) EPS Beats Sales Gain 14% - sharewise.com
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts - Investing.com
CareDx Publishes Landmark KOAR Study on AlloSure Efficacy in Kidney Transplant Surveillance in American Journal of Transplantation. - AInvest
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - BioSpace
CareDx Names Nathan Smith as New CFO - AInvest
Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings - Yahoo Finance
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates - Nasdaq
CareDx: Q2 Earnings Snapshot - San Antonio Express-News
CareDx Inc. Faces Q2 Loss with Revenue Below ExpectationsNews and Statistics - IndexBox
CareDx's Strategic Leadership Shift: How CFO Nathan Smith's Appointment Signals a New Era of Growth - AInvest
Caredx Inc earnings beat by $0.20, revenue fell short of estimates - Investing.com South Africa
CareDx narrows FY25 revenue view to $367M-$373M from $365M-$375M - TipRanks
CareDx Q2 Testing Volume Surges 20%, Narrows 2025 Revenue Outlook | CDNA Stock News - Stock Titan
CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation - Lelezard
AlloSure kidney transplant test shows strong predictive value for rejection By Investing.com - Investing.com Nigeria
Pinnacle West Q2 Earnings In Line With Estimates, Revenues Rise Y/Y - The Globe and Mail
CareDx ($CDNA) Is Paying a $20.25M Settlement to Investors — Here’s How to Get Your Share - TradingView
What are the technical indicators suggesting about CareDx IncFree Stock Market Return Analysis - Jammu Links News
What are the latest earnings results for CareDx IncGet alerts on high-potential stock breakouts - Jammu Links News
When is CareDx Inc stock expected to show significant growthStrong return on investment - Jammu Links News
Does CareDx Inc stock perform well during market downturnsDiscover dynamic stocks ready to soar - Jammu Links News
How does CareDx Inc compare to its industry peersAchieve consistent profits with disciplined trading - Jammu Links News
Is CareDx Inc stock overvalued or undervaluedExceptional portfolio growth - Jammu Links News
Should I hold or sell CareDx Inc stock in 2025Invest smarter with advanced market data - Jammu Links News
Why is CareDx Inc stock attracting strong analyst attentionStrongest growth potential - Jammu Links News
How volatile is CareDx Inc stock compared to the marketMaximize your returns with expert insights - Jammu Links News
What analysts say about CareDx Inc stockMaximize gains with data-driven trading alerts - Jammu Links News
What is the dividend policy of CareDx Inc stockFree Stock Market Return Analysis - Jammu Links News
What institutional investors are buying CareDx Inc stockTremendous financial leverage - Jammu Links News
Is CareDx Inc a growth stock or a value stockAchieve rapid financial growth with expert picks - Jammu Links News
No Bull | The Five Spot - The Globe and Mail
CareDx’s ALAMO Study: Advancing Lung Transplant Surveillance - TipRanks
CareDx’s HeartCare Study: A Game Changer in Heart Transplant Monitoring? - TipRanks
Caredx Inc (CDNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
0.79%
자본화:
|
볼륨(24시간):